دورية أكاديمية
Mass Testing for SARS-CoV-2 in 16 Prisons and Jails - Six Jurisdictions, United States, April-May 2020.
| العنوان: | Mass Testing for SARS-CoV-2 in 16 Prisons and Jails - Six Jurisdictions, United States, April-May 2020. |
|---|---|
| المؤلفون: | Hagan LM, Williams SP, Spaulding AC, Toblin RL, Figlenski J, Ocampo J, Ross T, Bauer H, Hutchinson J, Lucas KD, Zahn M, Chiang C, Collins T, Burakoff A, Bettridge J, Stringer G, Maul R, Waters K, Dewart C, Clayton J, de Fijter S, Sadacharan R, Garcia L, Lockett N, Short K, Sunder L, Handanagic S |
| المصدر: | MMWR. Morbidity and mortality weekly report [MMWR Morb Mortal Wkly Rep] 2020 Aug 21; Vol. 69 (33), pp. 1139-1143. Date of Electronic Publication: 2020 Aug 21. |
| نوع المنشور: | Journal Article |
| اللغة: | English |
| بيانات الدورية: | Publisher: U.S. Centers for Disease Control Country of Publication: United States NLM ID: 7802429 Publication Model: Electronic Cited Medium: Internet ISSN: 1545-861X (Electronic) Linking ISSN: 01492195 NLM ISO Abbreviation: MMWR Morb Mortal Wkly Rep Subsets: MEDLINE |
| أسماء مطبوعة: | Publication: Atlanta, GA : U.S. Centers for Disease Control Original Publication: [Atlanta] U. S. Dept. of Health, Education, and Welfare, Public Health Service, Center for Disease Control. |
| مواضيع طبية MeSH: | Mass Screening* , Prisons*, Clinical Laboratory Techniques/*statistics & numerical data , Coronavirus Infections/*epidemiology , Disease Outbreaks/*prevention & control , Pneumonia, Viral/*epidemiology, COVID-19 ; COVID-19 Testing ; Coronavirus Infections/diagnosis ; Coronavirus Infections/prevention & control ; Housing/statistics & numerical data ; Humans ; Pandemics/prevention & control ; Pneumonia, Viral/prevention & control ; Prevalence ; United States/epidemiology |
| مستخلص: | Preventing coronavirus disease 2019 (COVID-19) in correctional and detention facilities* can be challenging because of population-dense housing, varied access to hygiene facilities and supplies, and limited space for isolation and quarantine (1). Incarcerated and detained populations have a high prevalence of chronic diseases, increasing their risk for severe COVID-19-associated illness and making early detection critical (2,3). Correctional and detention facilities are not closed systems; SARS-CoV-2, the virus that causes COVID-19, can be transmitted to and from the surrounding community through staff member and visitor movements as well as entry, transfer, and release of incarcerated and detained persons (1). To better understand SARS-CoV-2 prevalence in these settings, CDC requested data from 15 jurisdictions describing results of mass testing events among incarcerated and detained persons and cases identified through earlier symptom-based testing. Six jurisdictions reported SARS-CoV-2 prevalence of 0%-86.8% (median = 29.3%) from mass testing events in 16 adult facilities. Before mass testing, 15 of the 16 facilities had identified at least one COVID-19 case among incarcerated or detained persons using symptom-based testing, and mass testing increased the total number of known cases from 642 to 8,239. Case surveillance from symptom-based testing has likely underestimated SARS-CoV-2 prevalence in correctional and detention facilities. Broad-based testing can provide a more accurate assessment of prevalence and generate data to help control transmission (4). Competing Interests: All authors have completed and submitted the International Committee of Medical Journal Editors form for disclosure of potential conflicts of interest. Anne C. Spaulding reports funding from the following entities to consult on COVID-19 control in correctional facilities: Harris County, Texas (funds to be paid to Emory University), the National Sheriff’s Association (funds to be paid to Emory University), and Guardian (travel funds only). Dr. Spaulding also reports grants from Gilead Sciences, the National Commission on Correctional Health Care, bioLytical Sciences, and Cellex outside the submitted work. No other potential conflicts of interest were disclosed by authors. |
| References: | MMWR Morb Mortal Wkly Rep. 2020 May 15;69(19):594-598. (PMID: 32407301) Clin Infect Dis. 2020 Jul 28;71(15):891-892. (PMID: 32221515) MMWR Morb Mortal Wkly Rep. 2020 Jul 03;69(26):836-840. (PMID: 32614816) MMWR Morb Mortal Wkly Rep. 2020 May 15;69(19):587-590. (PMID: 32407300) MMWR Morb Mortal Wkly Rep. 2020 Aug 11;69(32):1095-1099. (PMID: 32790655) JAMA Intern Med. 2020 Apr 28;:. (PMID: 32343355) Ann Intern Med. 2020 Jun 3;:. (PMID: 32491919) |
| تواريخ الأحداث: | Date Created: 20200821 Date Completed: 20200821 Latest Revision: 20201218 |
| رمز التحديث: | 20221213 |
| مُعرف محوري في PubMed: | PMC7439979 |
| DOI: | 10.15585/mmwr.mm6933a3 |
| PMID: | 32817597 |
| قاعدة البيانات: | MEDLINE |
Full Text Finder كن أول من يترك تعليقا!